Series E Convertible Preferred Stock (Details Narrative) - USD ($)	Apr. 12, 2023	Jan. 18, 2023	Jun. 10, 2022	Apr. 28, 2022	Jun. 30, 2023
Preferred stock, shares outstanding					0
Private Placement [Member]
Proceeds from private placement	$ 6,000,000.0
Common Stock [Member]
Common stock dividends, shares		31,933
Series E Convertible Preferred Stock [Member]
Conversion of stock, shares issued		200
Accrued dividends		$ 9,545
Series E Preferred Stock [Member]
Conversion of stock, shares issued	674,693
Conversion price, per share	$ 6.00
Series E Preferred Stock [Member] | Private Placement [Member]
Proceeds from private placement	$ 4,000,000
Harvard Bioscience Inc [Member] | Series E Convertible Preferred Stock [Member]
Litigation amount received			$ 4,000,000.0	$ 4,000,000.0
Temporary equity, stock issued			4,000
Temporary equity, issue price per share			$ 1,000